Reduction in life expectancy in Brazil after COVID-19.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34188224.
- Also identified by DOI 10.1038/s41591-021-01437-z and PMC identifier 8446334.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Brazil has been heavily affected by coronavirus disease 2019 (COVID-19). In this study, we used data on reported total deaths in 2020 and in January-April 2021 to measure and compare the death toll across states. We estimate a decline in 2020 life expectancy at birth (e<sub>0</sub>) of 1.3 years, a mortality level not seen since 2014. The reduction in life expectancy at age 65 (e<sub>65</sub>) in 2020 was 0.9 years, setting Brazil back to 2012 levels. The decline was larger for males, widening by 9.1% the female-male gap in e<sub>0</sub>. Among states, Amazonas lost 60.4% of the improvements in e<sub>0</sub> since 2000. In the first 4 months of 2021, COVID-19 deaths represented 107% of the total 2020 figures. Assuming that death rates would have been equal to 2019 all-cause rates in the absence of COVID-19, COVID-19 deaths in 2021 have already reduced e<sub>0</sub> in 2021 by 1.8 years, which is slightly larger than the reduction estimated for 2020 under similar assumptions.
Medical subject headings
- COVID-19
- Life Expectancy